Genocea Biosciences Inc (GNCAQ)
0.00
USD |
OTCM |
May 13, 16:00
Genocea Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.6174 |
| December 31, 2021 | 0.3245 |
| September 30, 2021 | 0.262 |
| June 30, 2021 | 2.411 |
| March 31, 2021 | 5.476 |
| December 31, 2020 | 1.543 |
| September 30, 2020 | 0.6802 |
| June 30, 2020 | 1.696 |
| March 31, 2020 | 1.039 |
| December 31, 2019 | 0.5354 |
| September 30, 2019 | 0.4238 |
| June 30, 2019 | 0.3573 |
| March 31, 2019 | 2.265 |
| December 31, 2018 | 2.021 |
| September 30, 2018 | 2.253 |
| June 30, 2018 | 1.044 |
| March 31, 2018 | 0.9524 |
| December 31, 2017 | -2.366 |
| September 30, 2017 | 4.282 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.8962 |
| March 31, 2017 | 0.5164 |
| December 31, 2016 | 0.3724 |
| September 30, 2016 | 0.2789 |
| June 30, 2016 | 0.2325 |
| March 31, 2016 | 0.2049 |
| December 31, 2015 | 0.1838 |
| September 30, 2015 | 0.1179 |
| June 30, 2015 | 0.1906 |
| March 31, 2015 | 0.1661 |
| December 31, 2014 | 0.3504 |
| September 30, 2014 | 0.2351 |
| June 30, 2014 | 0.2004 |
| March 31, 2014 | 0.1772 |
| December 31, 2013 | 6.844 |
| September 30, 2013 | 0.4025 |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.6416 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.262
Minimum
Sep 2021
5.476
Maximum
Mar 2021
1.280
Average
0.6488
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.79M |
| Total Liabilities (Quarterly) | 26.40M |
| Shareholders Equity (Quarterly) | 12.38M |